A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy (Q42252182)
Jump to navigation
Jump to search
scientific article published on 5 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy |
scientific article published on 5 December 2013 |
Statements
1 reference
A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy (English)
1 reference
Crystal Watson
1 reference
Anna Walker
1 reference
Stamatia T Alexopoulos
1 reference
Baris Deniz
1 reference
Ryan Arnold
1 reference
David Bates
1 reference
5 December 2013
1 reference
1 reference
30
1 reference
4
1 reference
629-635
1 reference
Identifiers
1 reference
1 reference